Compare Abeona Therapeutics Inc (ABEO) vs Allbirds Inc (BIRD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Allbirds Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Allbirds Inc trades at $2.59 (market cap $30.00M). The key difference: Abeona Therapeutics Inc is far larger — about 14× Allbirds Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Allbirds Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | BIRD | |
|---|---|---|
Market Cap | $421.19M | $30.00M |
Sector | Health | Consumer Cyclical |
52-Week High | $7.45 | $16.99 |
52-Week Low | $4.17 | $2.21 |
Enterprise Value | $276.10M | $48.86M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Allbirds Inc
Allbirds Inc is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products. Its primary source of revenue is from sales of shoes and apparel products in its directly owned digital and physical retail channels.
Read more on BIRD →
